Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

RNF113A2 Inhibitors

RNF113A2 is a protein encoded by the RNF113A2 gene, which belongs to the RING finger protein family. RING finger proteins are characterized by the presence of a RING (Really Interesting New Gene) domain, a specialized type of zinc finger that typically functions as an E3 ubiquitin-protein ligase. These ligases are crucial components of the ubiquitin-proteasome system, a cellular pathway responsible for the regulation of protein degradation, which plays a significant role in maintaining protein homeostasis within the cell.The RNF113A2 protein, through its RING domain, is thought to mediate the ubiquitination of specific substrate proteins, tagging them for recognition and subsequent degradation by the 26S proteasome. This process is essential for controlling the levels of proteins within the cell and for the timely removal of misfolded, damaged, or regulatory proteins that have served their purpose.

In addition to its role in protein turnover, RNF113A2 may be involved in various cellular processes, including signal transduction, cell cycle regulation, and the response to stress or DNA damage. The ubiquitin-mediated modification of proteins by RNF113A2 can alter their activity, localization, or interaction with other molecules, thus influencing diverse cellular pathways.Mutations or dysregulation of the RNF113A2 gene, and by extension the RNF113A2 protein, have been implicated in certain genetic disorders and may contribute to the development of disease. The study of RNF113A2 and its interactions with other proteins in the cell provides valuable insights into the intricate network of protein regulation and its impact on cellular function and health.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

A proteasome inhibitor that inhibits the degradation of ubiquitinated proteins, potentially influencing RNF113A2-related pathways.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Another proteasome inhibitor, which can affect the ubiquitin-proteasome system and thereby may indirectly impact RNF113A2 functions.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

An inhibitor of ubiquitin-activating enzyme E1, potentially affecting the ubiquitination process in which RNF113A2 is involved.

ATM/ATR Kinase Inhibitor Inhibitor

905973-89-9sc-202964
5 mg
$104.00
8
(1)

Inhibits NEDD8-activating enzyme, affecting the neddylation pathway which is closely related to ubiquitination.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Modulates the ubiquitin E3 ligase activity of the Cereblon complex, potentially impacting proteins involved in ubiquitination like RNF113A2.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$49.00
$367.00
$2030.00
18
(1)

Similar to Thalidomide, it affects the E3 ligase activity of Cereblon, influencing ubiquitination processes.

Pomalidomide

19171-19-8sc-364593
sc-364593A
sc-364593B
sc-364593C
sc-364593D
sc-364593E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$98.00
$140.00
$306.00
$459.00
$1224.00
$1958.00
1
(1)

Another IMiD compound that modulates the ubiquitin E3 ligase activity, indirectly influencing ubiquitination pathways.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

A specific inhibitor of the proteasome, impacting the degradation of ubiquitinated proteins and possibly affecting RNF113A2-related functions.

Carfilzomib

868540-17-4sc-396755
5 mg
$40.00
(0)

Proteasome inhibitor, affecting the breakdown of ubiquitinated proteins, which could indirectly impact RNF113A2.

PR 619

2645-32-1sc-476324
sc-476324A
sc-476324B
1 mg
5 mg
25 mg
$75.00
$184.00
$423.00
1
(0)

A broad-spectrum deubiquitinase inhibitor, potentially affecting ubiquitination dynamics related to RNF113A2.